Gestational diabetes mellitus: Risks and management during and after pregnancy

Nature Reviews Endocrinology

Volumn 8, Issue 11, 2012, Pages 639-649

  Buchanan, Thomas A ^a   Xiang, Anny H ^b   Page, Kathleen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Kaiser Permanente Southern California ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADVERSE OUTCOME; ARTICLE; BLOOD GLUCOSE MONITORING; BREAST FEEDING; CALORIC RESTRICTION; CESAREAN SECTION; DIABETIC PATIENT; DIET THERAPY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HUMAN; LIFESTYLE MODIFICATION; MATERNAL HYPERTENSION; MATERNAL WELFARE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; OBESITY; PERINATAL PERIOD; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SELF MONITORING;

ANIMALS; DIABETES, GESTATIONAL; DISEASE MANAGEMENT; FEMALE; HUMANS; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84867666814     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.96     Document Type: Article

References (81)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35 (Suppl. 1), S64-S71 (2012).
2. Buchanan, T. A., Xiang, A., Kjos, S. L. & Watanabe, R. M. What is gestational diabetes? Diabetes Care 30 (Suppl. 2), S105-S111 (2007). (Pubitemid 47036411)
3. Metzger, B. E. et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991-2002 (2008). (Pubitemid 351656454)
4. Metzger, B. E. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676-682 (2010).
5. Sacks, D. A. et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35, 526-528 (2012).
6. Ryan, E. A. Diagnosing gestational diabetes. Diabetologia 54, 480-486 (2011).
7. Long, H. Diagnosing gestational diabetes: can expert opinions replace scientific evidence. Diabetologia 54, 2211-2213 (2011).
8. Paglia, M. J. & Coustan, D. R. Gestational diabetes: evolving diagnostic criteria. Curr. Opin. Obstet. Gynecol. 23, 72-75 (2011).
9. Schafer, U. M. et al. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am. J. Obstet. Gynecol. 177, 1165-1171 (1997).
10. Dabelea, D. et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28, 579-584 (2005). (Pubitemid 40315316)
11. Ferrara, A., Kahn, H. S., Quesenberry, C. P., Riley, C. & Hedderson, M. M. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet. Gynecol. 103, 526-533 (2004). (Pubitemid 40459069)
12. Xiang, A. H. et al. Racial and ethnic disparities in diabetes risk after gestational diabetes. Diabetologia 54, 3016-3021 (2011).
13. Xiang, A. H. et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48, 848-854 (1999). (Pubitemid 29153086)
14. Petersen, J. S. et al. GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy. Diabetologia 39, 1329-1333 (1996). (Pubitemid 26356062)
15. Catalano, P. M., Tyzbir, E. D. & Sims, E. A. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13, 478-482 (1990). (Pubitemid 20145950)
16. Mauricio, D. et al. Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes shortly after pregnancy. Diabetes Nutr. Metab. 5, 237-241 (1992). (Pubitemid 23058806)
17. Kousta, E. et al. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet. Med. 18, 683-684 (2001). (Pubitemid 32823070)
18. Weng, J. et al. Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 25, 68-71 (2002). (Pubitemid 41070785)
19. Chen, Y., Liao, W. X., Roy, A. C., Loganath, A. & Ng, S. C. Mitochondrial gene mutations in gestational diabetes mellitus. Diabetes Res. Clin. Pract. 48, 29-35 (2000). (Pubitemid 30125826)
20. Catalano, P. M. et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am. J. Physiol. 264, E60-E67 (1993). (Pubitemid 23054688)
21. Catalano, P. M., Huston, L., Amini, S. B. & Kalhan, S. C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am. J. Obstet. Gynecol. 180, 903-916 (1999). (Pubitemid 29200557)
22. Homko, C., Sivan, E., Chen, X., Reece, E. A. & Boden, G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 86, 568-573 (2001). (Pubitemid 32207460)
23. Naylor, C. D., Sermer, M., Chen, E. & Sykora, K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? JAMA 275, 1165-1170 (1996). (Pubitemid 26113931)
24. O'Sullivan, J. B. Diabetes after GDM. Diabetes 40 (Suppl. 2), 131-135 (1991).
25. Xiang, A. H., Kjos, S. L., Takayanagi, M., Trigo, E. & Buchanan, T. A. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes 59, 2625-2630 (2010).
26. Xiang, A. H., Kawakubo, M., Trigo, E., Kjos, S. L. & Buchanan, T. A. Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care 33, 396-401 (2010).
27. Retnakaran, R. et al. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J. Clin. Endocrinol. Metab. 95, 670-677 (2010).
28. Sullivan, S. D., Umans, J. G. & Ratner, R. Gestational diabetes; implications for cardiovascular health. Curr. Diab. Rep. 12, 43-52 (2012).
29. Retnakaran, R. & Shah, B. R. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 181, 371-376 (2009).
30. Silverman, B. L. et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 40 (Suppl. 2), S121-S125 (1991).
31. Hillier, T. A. et al. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 30, 2287-2292 (2007). (Pubitemid 47359033)
32. Dabelea, D. et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case- Control Study. Diabetes Care 31, 1422-1426 (2008).
33. Krishnaveni, G. V. et al. Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children. Diabetes Care 33, 402-404 (2010).
34. Whitaker, R. C., Pepe, M. S., Seidel, K. D., Wright, J. A. & Knopp, R. H. Gestational diabetes and the risk of offspring obesity. Pediatrics 101, E9 (1998).
35. Catalano, P. M. et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am. J. Clin. Nutr. 90, 1303-1313 (2009).
36. Dabelea, D. et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49, 2208-2211 (2000).
37. Silverman, B. L., Rizzo, T. A., Cho, N. H. & Metzger, B. E. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 21 (Suppl. 2), B142-B149 (1998). (Pubitemid 28357047)
38. Crume, T. L. et al. The impact of in utero exposure to diabetes on childhood body mass index growth trajectories: the EPOCH study. J. Pediatr. 158, 941-946 (2011).
39. Nathan, D. M. et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32, 193-203 (2009).
40. [No authors listed] Screening for gestational diabetes mellitus: U. S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 148, 759-765 (2008).
41. Scott, D. A., Loveman, E., McIntyre, I. & Waugh, N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol. Assess. 6, 1-161 (2002).
42. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care, 15-23 (Health Canada, Ottawa, 1994).
43. Crowther, C. A. et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352, 2477-2486 (2005). (Pubitemid 41007863)
44. Landon, M. B. et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 361, 1339-1348 (2009).
45. Horvath, K. et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 340, c1395 (2010).
46. Ohno, M. S., Sparks, T. N., Cheng, Y. W. & Caughey, A. B. Treating mild gestational diabetes: a cost-effectiveness analysis. Am. J. Obstet. Gynecol. 205, 282.e1-282.e7 (2011).
47. Tuomilehto, J. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343-1350 (2001). (Pubitemid 32378388)
48. Buchanan, T. A. et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51, 2796-2803 (2002). (Pubitemid 34970933)
49. Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403 (2002). (Pubitemid 34437694)
50. Chaisson, J. L. et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359, 2072-2077 (2002).
51. Gerstein, H. C. et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: randomised controlled trial. Lancet 368, 1096-1105 (2006).
52. DeFronzo, R. A. et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N. Engl. J. Med. 364, 1104-1115 (2011).
53. Buchanan, T. A. (How) can we prevent type 2 diabetes? Diabetes 56, 1502-1507 (2007). (Pubitemid 46842593)
54. Xiang, A. H. et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55, 517-522 (2006). (Pubitemid 43343284)
55. Ratner, R. E. et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle intervention. J. Clin. Endocrinol. Metab. 93, 4774-4779 (2008).
56. Pettitt, D. J. & Knowler, W. C. Long-term effects of the intrauterine environment, birth weight, and breast-feeding on Pima Indians. Diabetes Care 21 (Suppl. 2), B138-B141 (1998). (Pubitemid 28357046)
57. Mayer-Davis, E. J. et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCh for diabetes in youth case-control study. Diabetes Care 31, 470-475 (2008).
58. Gillman, M. W. et al. Effect of treatment of gestational diabetes on obesity in the next generation. Diabetes Care 33, 964-968 (2010).
59. Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R. & Moore, P. M. Metformin versus insulin for treatment of gestational diabetes. N. Engl. J. Med. 358, 2003-2015 (2008). (Pubitemid 351656455)
60. Rowan, J. A. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 34, 2279-2284 (2011).
61. Knopp, R. H., Magee, M. S., Raisys, V. & Benedetti, T. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 40 (Suppl. 2), 165-171 (1991).
62. Peterson, C. M. & Jovanovic-Peterson, L. Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes 40 (Suppl. 2), 172-174 (1991).
63. rd. Effect of dietary carbohydrate on the glucose and insulin response to mixed caloric intake and exercise in both nonpregnant and pregnant women. Diabetes Care 21 (Suppl. 2), B107-B112 (1998).
64. Major, C. A., Henry, M. J., De Veciana, M. & Morgat, M. A. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet. Gynecol. 91, 600-604 (1998). (Pubitemid 28153052)
65. de Veciana, M. et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N. Engl. J. Med. 333, 1237-1241 (1995).
66. Naylor, C. D., Sermer, M., Chen, E. & Sykora, K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? JAMA 275, 1165-1170 (1996). (Pubitemid 26113931)
67. [No authors listed] Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58, 453-459 (2009).
68. Kjos, S. L. et al. A randomized controlled trial utilizing glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 24, 1904-1910 (2001). (Pubitemid 33716499)
69. Buchanan, T. A. et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 17, 275-283 (1994). (Pubitemid 24123407)
70. Langer, O. et al. Glycemic control in gestational diabetes mellitus\-how tight is tight enough: small for gestational age versus large for gestational age? Am. J. Obstet. Gynecol. 161, 646-653 (1989). (Pubitemid 19252777)
71. Bung, P., Artal, R., Khodiguian, N. & Kjos, S. Exercise in gestational diabetes. An optional therapeutic approach? Diabetes 40 (Suppl. 2), 182-185 (1991).
72. Jovanovic-Peterson, L. & Peterson, C. M. Is exercise safe or useful for gestational diabetic women? Diabetes 40 (Suppl. 2), 179-181 (1991).
73. Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M. & Gonzales, O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med. 343, 1134-1138 (2000).
74. Kjos, S. L. et al. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44, 586-591 (1995).
75. Kim, C., Newton, K. M. & Knopp, R. H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25, 1862-1868 (2002).
76. Hattersley, A. T. & Pearson, E. R. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology 147, 2657-2663 (2006). (Pubitemid 43764600)
77. Nathan, D. M. et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30, 753-759 (2007). (Pubitemid 46354366)
78. Peters, R. K., Kjos, S. L., Xiang, A. & Buchanan T. A. Long-term diabetogenic effect of a single pregnancy in women with previous gestational diabetes mellitus. Lancet 347, 227-230 (1996). (Pubitemid 26035248)
79. Ehrlich, S. F. et al. Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy. Obstet. Gynecol. 117, 1323-1330 (2011).
80. Kjos, S. L. et al. Oral contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes. JAMA 280, 533-538 (1998). (Pubitemid 28377672)
81. Xiang, A. H., Kawakubo, M., Kjos, S. L. & Buchanan, T. A. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 29, 613-617 (2006). (Pubitemid 44121124)